RxDoctor Payments Data

Krista Civiletti, DO

Family Medicine · Pittsboro, NCNPI 1548350382

Payments from drug & device makers

$3,917in general payments, 2019–2025

Across 42 payments — averaging $93.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exact Sciences$3K
  • Novo Nordisk$486
  • Amgen$285
  • Abbott$224
  • Lilly USA, LLC$121
  • Merck$17

What the payments were for

  • Consulting fees$1754%
  • Speaking & faculty fees$2,00051%
  • Travel & lodging$3238%
  • Food & beverage$1,41936%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Exact Sciences19$2,783
Novo Nordisk10$486
Amgen2$285
Abbott4$224
Lilly USA, LLC6$121
Merck1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,917 in reported general payments places this provider in the 85th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$37,804
Medicare patients
126
Services billed
631

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin31$53,705
MounjaroTirzepatide33$41,479
OzempicSemaglutide32$36,003
EliquisApixaban17$21,743
Repatha SureclickEvolocumab13$7,331
LinzessLinaclotide11$5,518
SymbicortBudesonide/Formoterol Fumarate13$3,299
Amiodarone Hcl14$1,762
Gabapentin106$1,472
Levothyroxine Sodium117$1,440
Atorvastatin Calcium125$1,413
Valsartan43$1,323
Bupropion XlBupropion Hcl46$1,099
Metoprolol Succinate63$960
Rosuvastatin Calcium84$883

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$121$41,47933 claims
Novo NordiskOzempic$486$36,00332 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Pittsboro

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →